Last updated on February 2018

Risk Factors in Tachycardiomyopathy

Brief description of study

Decision between rate control and rhythm control can be a challenge in clinical practice. While there is some guiding evidence, we still lack a comprehensive insight into different subgroups of patients that will benefit from a rhythm control treatment.

EMPATHY is a prospective clinical study in patients presenting with heart failure and a tachyarrhythmic rhythm disturbance. Biomarkers, routinely obtained results from clinical examinations, and results from endomyocardial biopsies shall be evaluated to identify patients which have better outcome from a rhythm control strategy by ablation therapy or, if contraindicated by pharmacological rhythm control.

This study is designed to identifying risk factors and subgroups profiting from rhythm restoration and therefore improve current therapeutic approaches and the rate of recurrence-free survival.

Clinical Study Identifier: NCT03418467

Contact Investigators or Research Sites near you

Start Over

Peter Seizer, MD

Universit tsklinikum T bingen, Medizinische Klinik III (Kardiologie)
Tübingen, Germany
  Connect »